PTC Therapeutics Inc to Host PTC518 Huntington Disease Deep Dive Webinar Transcript
Good day, and thank you for standing by. Welcome to the PTC Huntington's Disease Deep Dive Conference Call. (Operator Instructions). Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your host today, Kylie O'Keefe, Senior Vice President, Commercial and Corporate Strategy. Please go ahead.
' -
Good morning, everyone. Thank you for joining us today for the first addition to our 2021 deep dive series. Today, we will be focused on our PTC518 program in Huntington's disease.
Joining me on today's call is our Chief Executive Officer, Dr. Stuart Peltz; our Chief Development Officer, Dr. Matthew Klein; and our Executive Director of Biology, Dr. Anu Bhattacharyya. Slides are available on the Investors section of the website for you to follow along during the presentation today.
I will now pass the call over to our Chief Executive Officer, Stuart Peltz. Stu?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |